VertiFlex Inc.
-
Financial
Boston Scientific Closes Acquisition Of Vertiflex, Inc.
MARLBOROUGH, Mass., June 11, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Vertiflex, Inc., a privately-held…
Read More » -
Spine
Vertiflex® Announces Publication of Data Analysis Showing 85% Reduction in Patients Using Opioids After Treatment With Superion® Indirect Decompression System
November 20, 2018 CARLSBAD, Calif.–(BUSINESS WIRE)–Vertiflex® Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis, announced additional…
Read More » -
Financial
Vertiflex, Inc. Completes $40 Million Financing Round
March 08, 2017 CARLSBAD, Calif.–(BUSINESS WIRE)–Vertiflex, Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis, today announced…
Read More » -
MCRA Assists VertiFlex, Inc. with Obtaining FDA PMA Approval for the Superion® Interspinous Spacer System
WASHINGTON, June 24, 2015 /PRNewswire-USNewswire/ — Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) announced today its role in the successful Premarket Approval (PMA) application…
Read More » -
Hospitals
VertiFlex® Inc. Announces FDA PMA Approval for the Superion® Interspinous Spacer VertiFlex
VertiFlex® Inc. a leading innovator of advanced minimally invasive interventions for spinal stenosis announced today that the U.S. Food and Drug…
Read More »